1 Min Read
Oct 13 (Reuters) - Innate Pharma SA :
* Preliminary safety and clinical activity results for IPH4102 to be presented at the 3WCCL Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.